CG
QTTB icon

Carlyle Group’s Q32 Bio QTTB Stock Holding History

Carlyle Group’s Portfolio QTTB Stock Details QTTB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$7.08M Hold
1,102,741
– – 0.07% 7
2025
Q4 		$3.62M Hold
1,102,741
– – 0.03% 8
2025
Q3 		$2.13M Hold
1,102,741
– – 0.05% 12
2025
Q2 		$1.62M Hold
1,102,741
– – 0.03% 15
2025
Q1 		$1.81M Hold
1,102,741
– – 0.05% 17
2024
Q4 		$3.78M Hold
1,102,741
– – 0.09% 14
2024
Q3 		$48.6M Hold
1,102,741
– – 5.1% 5
2024
Q2 		$19.2M Hold
1,102,741
– – 1.82% 10
2024
Q1 		$18.1M Buy
+1,102,741
New +$15.2M 1.14% 12

Other funds holding QTTB

O
OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $758M AUM 124.8% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
S
Sanofi Paris, France $336M AUM 126.85% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return